Samsung Biologics Receives Presidential Award at Government Awards for Sustainable Management Excellence

Samsung Biologics announced on the 15th that it received the highest honor, the Presidential Award, at the '2023 Sustainable Management Government Awards' hosted by the Ministry of Trade, Industry and Energy and the Ministry of SMEs and Startups.

Samsung Biologics received the Presidential Award at the '2023 Sustainable Management Merit' ceremony held on the 14th at the FKI Tower in Yeouido, Seoul. Seung-ryeol Lee, Director General of Industrial Policy at the Ministry of Trade, Industry and Energy (left), is presenting the Presidential Award to Dong-jung Kim, Head of the Management Support Center at Samsung Biologics.
[Photo by Samsung Biologics]

The Sustainable Management Government Awards are given to companies that contribute to creating social value through sustainable management, comprehensively evaluating achievements in the ESG (Environment, Social, Governance) sector and the implementation status of national policy tasks.

Samsung Biologics was recognized for its contributions in ▲ responding to climate change and environmental management achievements ▲ respecting human rights, strengthening safety and health management, and fostering win-win cooperation ▲ establishing ESG management systems and enhancing risk management.

First, in the Environment sector, the company declared a 2050 carbon neutrality (Net Zero) goal and is actively implementing concrete measures to achieve it. Compared to 2021, it has reduced energy consumption in business operations and manufacturing, while improving infrastructure for eco-friendly workplaces through the use of solar energy and purchasing renewable energy. Additionally, it is expanding global climate crisis response initiatives such as risk and opportunity analysis through the publication of TCFD reports and participation in the Sustainable Market Initiative (SMI).

In the Social sector, Samsung Biologics conducts human rights impact assessments to manage potential human rights risks and strives for human rights management throughout its operations. Furthermore, it strengthens the creation of safe workplaces and prevention of industrial accidents through the operation of the Industrial Safety and Health Committee and certification of the Business Continuity Management System (ISO 22031). At the same time, it expands ESG activities across the entire value chain through supply chain ESG evaluations.

In the Governance sector, the company has established an ESG management system by operating an ESG committee and creating a dedicated ESG group, and has established an anti-corruption management system through ISO 37001 certification. Moreover, it has enhanced the independence and transparency of the board of directors by forming committees and the board centered on outside directors.

On the day of the award, Samsung Biologics shared its sustainable management activities and future vision with participating companies during the ESG Best Practices presentation session, which is held exclusively for Presidential Award-winning companies.

John Rim, President of Samsung Biologics, said, "As the global number one (NO.1) contract development and manufacturing organization (CDMO), we will continuously discover and promote exemplary ESG implementation plans that can lead the industry," adding, "We will take the lead to ensure that Samsung Biologics’ efforts for sustainable management spread throughout the pharmaceutical and bio industries."

Samsung Biologics received the Presidential Award at the '2023 Sustainable Management Awards' ceremony held on the 14th at the FKI Tower in Yeouido, Seoul. Seung-ryeol Lee, Director General of Industrial Policy at the Ministry of Trade, Industry and Energy (left), and Dong-jung Kim, Head of the Management Support Center at Samsung Biologics, are posing for a commemorative photo at the awards ceremony.
[Photo by Samsung Biologics]

This content was produced with the assistance of AI translation services.